1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
28 
compliance with the guidelines. Research in the private 
sector is not covered by the guidelines, ami can only be 
governed by legislation. We note that PM A and individual 
company representatives have committed their organizations 
to volunteer compliance with the federal guidelines. 
While supporting the present proposed guidelines, 
we are concerned that Win retain surveillance over local 
biosafety committees. It is important that NIH have the 
authority to assure uniform, national standards of com- 
pliance with these guidelines. In the absence of over- 
riding federal legislation, the steps defined in the 
July 28, 1978 guidelines represent an acceptable interim 
procedure . 
Thank you. 
MR. LI8ASSI: Thank you very much. 
I would like to call as the next witness Congress- 
man Ottinger who has limited time. So we would like to 
interrupt the list of speakers and call on him next. 
Thank you, Congressman Ottinger. 
MR. OTTINGER: Thank you very much, Mr. Chairman 
and members of the Panel. I appreciate you giving me this 
opportunity to appear before you this morning. I will be 
brief . 
I would just like to make a few remarks this 
morning about the urgency with which I am convinced HEW 
[120] 
